Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)

Lee, J. W.; Lee, Y-g.; Lee, G-w.; Jung, H. A.; Kim, K-p.; Kim, T-y.; Ryu, H.; Ryu, M. H.; Ahn, M. S.; Yun, H.; Ahn, S.; Shim, H. S.; Kim, J.; Sim, J.; Kim, S. Y.; Kim, J. H.; Lee, S.

doi:10.1016/j.annonc.2024.10.504

상세 보기

Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)

Lee, J. W.;
Lee, Y-g.;
Lee, G-w.;
Jung, H. A.;
Kim, K-p.;
외 12명

Citations

WEB OF SCIENCE

0

Citations

SCOPUS

0

제목: Erlotinib plus bevacizumab in patients with metastatic solid tumors with EGFR amplification: Results from the KOSMOS-II (KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced solid tumors, KCSG AL 22-09)

저자: Lee, J. W.; Lee, Y-g.; Lee, G-w.; Jung, H. A.; Kim, K-p.; Kim, T-y.; Ryu, H.; Ryu, M. H.; Ahn, M. S.; Yun, H.; Ahn, S.; Shim, H. S.; Kim, J.; Sim, J.; Kim, S. Y.; Kim, J. H.; Lee, S.

DOI: 10.1016/j.annonc.2024.10.504

발행일: 2024-12

유형: Meeting Abstract

저널명: Annals of Oncology

권: 35

페이지: S1580 ~ S1580

ScholarWorks@경상국립대학교

상세 보기